Journal
AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Volume 134, Issue 3, Pages 472-477Publisher
OXFORD UNIV PRESS INC
DOI: 10.1309/AJCPHMYT93HUIZKW
Keywords
Chronic lymphocytic leukemia; Serum thymidine kinase 1; Prognostic factors
Categories
Ask authors/readers for more resources
Serum thymidine kinase 1 (TK1) levels have been reported to have prognostic significance in patients with chronic lymphocytic leukemia (CLL). Until recently, serum TK1 levels were assessed using inconvenient radioenzyme assays. In this study, we used a novel chemiluminescence assay to assess serum TK1 levels in patients with CLL at the time of first examination. We show that high serum TK1 levels predict poorer overall survival and correlate with unmutated immunoglobulin variable region genes, CD38 and ZAP-70 expression, and subsequent risk of developing large B-cell lymphoma (Richter syndrome). Similar findings were observed in a subset of patients treated with current fludarabine-based chemotherapy regimens. We suggest that serum TK1 levels analyzed using this convenient chemiluminescence assay may be useful in the risk assessment of patients with CLL.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available